Table 1 Demographic and clinical characteristics
From: Patterns of foot complaints in systemic lupus erythematosus: a cross sectional survey
Characteristic | Value |
|---|---|
Sex, n (%) | Female: 117 (89) |
Male: 14 (11) | |
Age (years), mean (SD) | 51 (15) |
Disease duration, mean (SD) | 12.5 (11) |
BMI (Kg/m2), mean (SD) | 27.7 (6.4) |
Current smoker, n (%) | 27 (21) |
Employment status, n (%) | |
Paid work | 68 (52) |
Not working | 32 (24) |
Retired | 20 (15) |
Unpaid work | 5 (4) |
Sick leave | 2 (2) |
Full-time education | 3 (2) |
Not stated | 1 (1) |
Ethnicity, n (%) | |
New Zealand European | 71 (54) |
Pacific Island | 23 (18) |
Asian | 24 (19) |
Māori | 11 (8) |
Early morning stiffness, n (%) | 96 (68) |
Early morning stiffness, duration, hours, mean (SD) | 2.1 (5.4) |
Hydroxychloroquine use, n (%) | 97 (74) |
Azathioprine use, n (%) | 25 (19) |
Methotrexate use, n (%) | 19 (14) |
Mycophenolate use, n (%) | 6 (5) |
Cyclophosphamide use, n (%) | 3 (2) |
Oral glucocorticoids use, n (%) | 55 (42) |
Non-steroidal anti-inflammatory drug use, n (%) | 29 (22) |
Rituximab use, n (%) | 5 (4) |